that's a HUGE leap and the Omidriaassure program is nothing like what Valeant is doing. Quit with the moronic scare tactics based on ZERO facts
This gives long term investors a chance to accumulate. Look at it as an opportunity that the sales were a bit slow out of the gate
I'm not so optimistic on the milestone payments or EU. I think 721 update in early Jan, meeting with FDA in December I think? I'm more hopeful that next call will show Omidria getting to $20M quarterly rev.
If, and that's a big if, GD is correct and by mid 2016 they are cash flow neutral across the company what would Omidria sales need to be? They are burning $15M per quarter? So that means that he feels that Omidiria sales will be able to cover this burn rate, so say $5M month of Omidiria sales by mid 2016 at least??
100% correct, tredleon. A lot of people here that are looking for a 5 bagger overnight, if only it were that easy
you have no idea if they are willing to pay. way too early to tell if oms721 will even work, need to get to stage 3 before it's worth it for another company
Yes look at a alexion and how long it took them to get to those Rev numbers. Probably not the right investment for you if looking for quivk trading profits